Phase 1 ISAR InflEx Trial: Exercise Inflammation CVD

A new Phase 1 clinical trial (NCT07543666) studying the relationship between exercise modality and systemic inflammation in sedentary, obese adults has been registered with ClinicalTrials.gov. The trial will compare three exercise interventions—moderate-intensity, vigorous-intensity, and short-duration maximal exercise—to evaluate their respective effects on inflammatory markers and immune function as potential cardiovascular disease prevention strategies. The study targets patients with obesity or overweight and a sedentary lifestyle, both established risk factors for chronic low-grade inflammation and CVD.

Healthcare providers and clinical investigators should note this trial as part of the broader evidence base on exercise-based therapeutic interventions for inflammatory and cardiometabolic conditions. While the trial itself does not create immediate compliance obligations, investigators conducting similar exercise-intervention or anti-inflammatory therapeutic research should ensure their protocols align with current ClinicalTrials.gov registration requirements and applicable GCP standards. This registry entry reflects ongoing regulatory expectations for transparency in clinical research involving human subjects.